Patents Assigned to Functional Neuromodulation Inc.
-
Publication number: 20150142089Abstract: Methods and apparatus for inducing neurogenesis within a human. The invention utilizes an implantable signal generator to deliver high frequency stimulation to deep brain tissue elements. The implanted device delivers treatment therapy to the brain to thereby induce neurogenesis by the human. A sensor may be used to detect various symptoms of nervous system discovery. A microprocessor algorithm may then analyze the output from the sensor to regulate the stimulation and/or drug therapy delivered to the brain.Type: ApplicationFiled: November 15, 2013Publication date: May 21, 2015Applicant: Functional Neuromodulation Inc.Inventors: Andres M. Lozano, Hiroki Toda
-
Patent number: 8868191Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.Type: GrantFiled: January 22, 2013Date of Patent: October 21, 2014Assignee: Functional Neuromodulation, Inc.Inventor: Andres M. Lozano
-
Publication number: 20140039393Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.Type: ApplicationFiled: January 22, 2013Publication date: February 6, 2014Applicant: Functional Neuromodulation Inc.Inventor: Andres M. Lozano
-
Publication number: 20140025133Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.Type: ApplicationFiled: September 23, 2013Publication date: January 23, 2014Applicant: Functional Neuromodulation Inc.Inventor: Andres M. Lozano
-
Publication number: 20130289385Abstract: Methods and apparatus for screening patients prior to deep brain stimulation to treat cognitive function are provided. One or more patient parameters are processed to produce results. A comparison of the results to a threshold indicates the applicability of the deep brain stimulation therapy.Type: ApplicationFiled: October 19, 2012Publication date: October 31, 2013Applicant: Functional Neuromodulation, Inc.Inventors: Andres Lozano, J. Christopher Flaherty
-
Patent number: 8565883Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.Type: GrantFiled: November 30, 2012Date of Patent: October 22, 2013Assignee: Functional Neuromodulation Inc.Inventor: Andrew Lozano
-
Publication number: 20130231709Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.Type: ApplicationFiled: November 30, 2012Publication date: September 5, 2013Applicant: Functional Neuromodulation, Inc.Inventor: Andres Lozano
-
Patent number: 8380304Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.Type: GrantFiled: November 4, 2011Date of Patent: February 19, 2013Assignee: Functional Neuromodulation, Inc.Inventor: Andres M. Lozano
-
Patent number: 8346365Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.Type: GrantFiled: April 26, 2011Date of Patent: January 1, 2013Assignee: Functional Neuromodulation, Inc.Inventor: Andres M. Lozano
-
Publication number: 20120053647Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.Type: ApplicationFiled: November 4, 2011Publication date: March 1, 2012Applicant: Functional Neuromodulation Inc.Inventor: Andres M. Lozano
-
Publication number: 20120016430Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.Type: ApplicationFiled: April 26, 2011Publication date: January 19, 2012Applicant: Functional Neuromodulation, Inc.Inventor: Andres M. Lozano
-
Patent number: 8078275Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.Type: GrantFiled: December 16, 2005Date of Patent: December 13, 2011Assignee: Functional Neuromodulation Inc.Inventor: Andres M. Lozano